Fertility

SenesTech Announces First Quarter 2024 Financial Results

Retrieved on: 
torsdag, maj 9, 2024

PHOENIX, May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024.

Key Points: 
  • PHOENIX, May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024.
  • Record quarterly revenues during Q1 2024 of $415,000, an increase of 78% compared to Q1 2023.
  • Expanding distribution to the do-it-yourself market through launch of dedicated Amazon store planned in May 2024.
  • "In addition to the strong performance in the first quarter, we have achieved key commercial and development milestones which help set the stage for the rest of 2024.

Progyny, Inc. Announces First Quarter 2024 Results

Retrieved on: 
torsdag, maj 9, 2024

Fertility benefit services revenue was $169.8 million, an 8.0% increase from the $157.1 million reported in the first quarter of 2023.

Key Points: 
  • Fertility benefit services revenue was $169.8 million, an 8.0% increase from the $157.1 million reported in the first quarter of 2023.
  • Adjusted EBITDA margin was 18.1%, a slight increase from the 17.9% Adjusted EBITDA margin in the first quarter of 2023.
  • During the first quarter of 2024, the Company purchased 723,577 shares for $26.4 million through the program.
  • The Company had 451 clients as of March 31, 2024, as compared to 379 clients as of March 31, 2023.

ARC Fertility Named Finalist for Two Categories at FemTech World Awards 2024

Retrieved on: 
tisdag, maj 7, 2024

ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its selection as a finalist in two categories at the recently held prestigious FemTech World Awards 2024 ceremony.

Key Points: 
  • ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly announces its selection as a finalist in two categories at the recently held prestigious FemTech World Awards 2024 ceremony.
  • The FemTech Awards, recognizing outstanding achievements in women's health technology, shortlisted ARC for the "Company of the Year," sponsored by Guidea and "Gender Inclusive Employer," sponsored by Wellbeing of Women.
  • “Our FertilityNow app exemplifies the ability of FemTech to empower patients by providing a user-friendly platform that facilitates informed decision-making and personalized fertility journeys,” says Dr. Adamson.
  • “Through a strategic fusion of personalized care, virtual accessibility, evidence-based practices, user-friendly interfaces and cutting-edge apps, ARC Fertility continues to redefine the future of reproductive care in a concise and impactful manner.”

Dr. Holly Mehr Joins Fertility & Surgical Associates of California

Retrieved on: 
måndag, maj 6, 2024

Fertility & Surgical Associates of California (FSAC) is pleased to welcome Dr. Holly Mehr MD, MSEd, double board certified in Reproductive Endocrinology and Obstetrics and Gynecology, to our clinic.

Key Points: 
  • Fertility & Surgical Associates of California (FSAC) is pleased to welcome Dr. Holly Mehr MD, MSEd, double board certified in Reproductive Endocrinology and Obstetrics and Gynecology, to our clinic.
  • Dr. Mehr is now scheduling new patient appointments at our Santa Monica location.
  • Your goals are my goals, and we work together to find the best path forward,” said Dr. Mehr.
  • Dr. Mehr completed her undergraduate studies at Wesleyan University and her medical degree at the Icahn School of Medicine at Mount Sinai.

Leveraging Lived Experience, Clinical & User-Generated Data, and Engaging Community Partners Are Key Takeaways from The Nation's Largest Black Maternal Health Conference

Retrieved on: 
tisdag, maj 7, 2024

BOSTON, May 7, 2024 /PRNewswire-PRWeb/ -- The Center for Black Maternal Health and Reproductive Justice at Tufts University School of Medicine recently hosted the 7th Annual Black Maternal Health Conference, the nation's largest convening focused on global Black maternal health outcomes. During the two-day event, organizers created a one-of-a-kind space to discuss innovations to end the adverse maternal health outcomes experienced by Black Women.

Key Points: 
  • The Center for Black Maternal Health and Reproductive Justice at Tufts University School of Medicine Hosts Innovators, Health Advocates, Practitioners, and Policy Makers to Advance Maternal Health Equity.
  • BOSTON, May 7, 2024 /PRNewswire-PRWeb/ -- The Center for Black Maternal Health and Reproductive Justice at Tufts University School of Medicine recently hosted the 7th Annual Black Maternal Health Conference, the nation's largest convening focused on global Black maternal health outcomes.
  • During the two-day event, organizers created a one-of-a-kind space to discuss innovations to end the adverse maternal health outcomes experienced by Black Women.
  • The 8th Annual Black Maternal Health Conference will be held on April 4, 2025, and will center on the important role of fathers in addressing Black maternal health disparities.

NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People with Cancer

Retrieved on: 
måndag, maj 6, 2024

WASHINGTON, May 6, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted an oncology policy summit, today, focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment. Speakers covered a wide range of topics, within the context of gender and sex, intimacy, fertility and reproductive health, treatment side-effects, and the impact of a changing policy landscape in the wake of new laws and judicial decisions.

Key Points: 
  • WASHINGTON, May 6, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted an oncology policy summit, today, focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment.
  • These evidence-based expert consensus recommendations feature best practices for addressing sexual health, fertility, hormone-related symptoms, and many other late and long-term effects from cancer.
  • "It is so important that education about sexual and reproductive health be included into the training of cancer clinicians if these critical health issues are to be addressed in patients' comprehensive cancer care."
  • Two afternoon keynote speakers shared first-hand looks at the issue of reproductive health and fertility preservation for people undergoing cancer care.

Olive Fertility Centre Victoria Welcomes New Fertility Specialist Dr. Riki Dayan

Retrieved on: 
måndag, maj 6, 2024

VICTORIA, BC, May 6, 2024 /PRNewswire-PRWeb/ -- Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team. "We are delighted to welcome Dr. Dayan to Olive Fertility," says Olive co-director Dr. Niamh Talon. "With her expertise in fertility, her dedication to education and her focus on whole person, patient-centred care, Dr. Dayan is an invaluable addition to the Olive Team."

Key Points: 
  • Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team.
  • VICTORIA, BC, May 6, 2024 /PRNewswire-PRWeb/ -- Olive Fertility Centre is pleased to announce that Dr. Riki Dayan MD FRCSC has joined the Olive Fertility Victoria Team.
  • "We are delighted to welcome Dr. Dayan to Olive Fertility," says Olive co-director Dr. Niamh Talon.
  • "With her expertise in fertility, her dedication to education and her focus on whole person, patient-centred care, Dr. Dayan is an invaluable addition to the Olive Team."

Studies Indicate Environmental Factors Can Impact Urologic Health

Retrieved on: 
fredag, maj 3, 2024

Researchers will present environmental and urological health study findings in San Antonio, Texas, from May 3 to 6.

Key Points: 
  • Researchers will present environmental and urological health study findings in San Antonio, Texas, from May 3 to 6.
  • Stacy Loeb, MD, Urology and Population Health professor at NYU Langone Health, moderated a virtual press session with the abstract authors, providing key insights into their research.
  • “It’s great that these studies are happening so we can get a better sense of how some of these environmental factors may affect things like fertility and urological cancer risk,” said Dr. Loeb.
  • It sounds like, in these cases, more studies are needed to follow up on these findings on an individual level.”
    The following abstracts are covered in the moderated panel:

Redfin Report: The Pool of People Taking Out Mortgages In America Is Becoming Less White

Retrieved on: 
fredag, maj 3, 2024

While that’s a far higher share than any other group, it’s down from 64% in 2022 and 70.4% in 2018.

Key Points: 
  • While that’s a far higher share than any other group, it’s down from 64% in 2022 and 70.4% in 2018.
  • Meanwhile, the share of new mortgages taken out by Hispanic buyers increased to 14% in 2023 from 12.6% in 2022 and 11% in 2018.
  • “The pool of homebuyers taking out mortgages is becoming less white because America is becoming more diverse, and many people of color are in their prime homebuying years,” said Redfin Senior Economist Elijah de la Campa.
  • White people took out 1,582,643 mortgages in 2023, down 22.1% from a year earlier and down 31.3% from 2018.

National Women’s Law Center and Law Firm Emery Celli Brinckerhoff Abady Ward & Maazel, LLP Announce Settlement of Class Action Lawsuit Against Aetna Over LGBTQ+ Fertility Coverage

Retrieved on: 
fredag, maj 3, 2024

v. Aetna , filed in September 2021, the plaintiffs challenged Aetna’s definition of infertility, alleging it led to unequal insurance coverage treatment for LGBTQ+ couples.

Key Points: 
  • v. Aetna , filed in September 2021, the plaintiffs challenged Aetna’s definition of infertility, alleging it led to unequal insurance coverage treatment for LGBTQ+ couples.
  • Aetna will re-process eligible insurance claims to reimburse class members for their out-of-pocket artificial insemination cycles, up to the plan limits.
  • Aetna will also separately pay all the costs of the administrator and special master who will allocate the common fund.
  • If you believe you are in the class of individuals covered by this settlement, please visit this page or contact: 1-800-205-6861.